Orion Biotechnology Secures $11.5M Series A Financing

Ontario Industry Updates
Written By Doriane Rey
orion-logo-large.png

Orion Biotechnology Canada Ltd., a clinical-stage biotechnology company, recently announced that it has raised $11.5M USD in a Series A financing. The oversubscribed round was led by Keiretsu Forum, a global group of investors and included corporate/institutional investors, venture capitalists and existing shareholders.

Doriane Rey
Previous

Ontario Launching New $30 Million Surgical Innovation Fund
Next

Toronto biotech startup Adela raises $60-million from top U.S. investors